HIMS
HEALTHCAREHims & Hers Health Inc - Class A
$26.88+0.55 (+2.09%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving HIMS Today?
No stock-specific AI insight has been generated for HIMS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$13.74$70.43
$26.88
Fundamentals
Market Cap$5.9B
P/E Ratio50.3
EPS$0.51
Dividend Yield—
Dividend / Share—
ROE0.3%
Profit Margin0.1%
Debt / Equity—
Trading
Volume14.9M
Avg Volume (10D)—
Shares Outstanding222.7M
HIMS News
24 articles- Can Platform Expansion Support Hims & Hers Stock Before Q1 Earnings?Yahoo Finance·May 8, 2026
- Senseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 7, 2026
- Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 6, 2026
- Is It Too Late To Consider Hims & Hers Health (HIMS) After Recent Share Price VolatilityYahoo Finance·May 5, 2026
- Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to NoteYahoo Finance·May 5, 2026
- Hims & Hers Expands DTC Platform to Broaden Access to Personal CareYahoo Finance·May 5, 2026
- 1 Stock Under $50 with Impressive Fundamentals and 2 We IgnoreYahoo Finance·May 5, 2026
- Amazon One Medical GLP-1 Program Evaluated: How the New Program Works, What It Costs, and What Cash-Pay Patients Should Know FirstYahoo Finance·May 4, 2026
- Hims & Hers Health, Inc. (HIMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseYahoo Finance·May 4, 2026
- Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now?Yahoo Finance·May 3, 2026
- 1 Russell 2000 Stock Worth Your Attention and 2 That UnderwhelmYahoo Finance·May 2, 2026
- Data Breach Lawsuits Test Hims And Hers Health Valuation And MomentumYahoo Finance·May 1, 2026
- HIMS vs. TDOC: Which Digital Health Stock Offers Better Upside Now?Yahoo Finance·Apr 30, 2026
- Hims & Hers Expands Digital-First Access to Personalized HealthcareYahoo Finance·Apr 29, 2026
- Hims & Hers Health, Inc. (HIMS) is a Top-Ranked Momentum Stock: Should You Buy?Yahoo Finance·Apr 29, 2026
- Why Hims & Hers Health (HIMS) Shares Are Trading Lower TodayYahoo Finance·Apr 29, 2026
- Hims Board Shakeup Highlights Marketing Focus And Customer Growth MetricsYahoo Finance·Apr 29, 2026
- Erasca Stock Sinks 48% in Race for Pancreatic Cancer Miracle Drug. What’s Behind the Sell-Off.Yahoo Finance·Apr 28, 2026
- OMCL vs. HIMS: Which Stock Should Value Investors Buy Now?Yahoo Finance·Apr 28, 2026
- BrightSpring Before Q1 Earnings: Buy, Sell or Hold the Stock Now?Yahoo Finance·Apr 28, 2026
- SpaceX Goes on $60 Billion AI Buying SpreeThe Motley Fool·Apr 27, 2026
- 3 Sectors to Buy While They’re Down and 1 to Walk Away FromInvesting.com·Apr 7, 2026
- Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data BreachGlobeNewswire Inc.·Apr 3, 2026
- Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription PlanBenzinga·Mar 31, 2026
All 24 articles loaded
Price Data
Open$26.87
Previous Close$26.33
Day High$27.07
Day Low$25.80
52 Week High$70.43
52 Week Low$13.74
52-Week Range
$13.74$70.43
$26.88
Fundamentals
Market Cap$5.9B
P/E Ratio50.3
EPS$0.51
Dividend Yield—
Dividend / Share—
ROE0.3%
Profit Margin0.1%
Debt / Equity—
Trading
Volume14.9M
Avg Volume (10D)—
Shares Outstanding222.7M
About Hims & Hers Health Inc - Class A
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San Francisco, California.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—